BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12894483)

  • 1. In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary.
    Nagy E; Marton A; Hajdú E
    Acta Microbiol Immunol Hung; 2003; 50(2-3):119-24. PubMed ID: 12894483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections.
    Kang JH; Lee SY; Kim JH; Hur JK; Lee KY
    Jpn J Antibiot; 2010 Feb; 63(1):11-7. PubMed ID: 20836403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
    Li J; Zhang Y; Chen Y; Hao F; Chen Y
    Chin Med J (Engl); 2000 Jul; 113(7):628-31. PubMed ID: 11776034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).
    Fritsche TR; Biedenbach DJ; Jones RN
    J Chemother; 2008 Apr; 20(2):170-4. PubMed ID: 18467241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefditoren and community-acquired lower respiratory tract infections (corrected)].
    Barberán J; Mensa J
    Rev Esp Quimioter; 2009 Sep; 22(3):144-50. PubMed ID: 19662548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of cefditoren against respiratory pathogens.
    Clark CL; Nagai K; Dewasse BE; Pankuch GA; Ednie LM; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2002 Jul; 50(1):33-41. PubMed ID: 12096004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998.
    Reinert RR; Al-Lahham A; Lütticken R
    J Antimicrob Chemother; 2001 Aug; 48(2):279-81. PubMed ID: 11481301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
    Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro Activity of Cefditoren against Middle Ear Fluid Isolates from Costa Rican Children with Otitis Media.
    Ulloa C; Guevara S; Soley C; Abdelnour A; Arguedas A
    Chemotherapy; 2014; 60(4):211-8. PubMed ID: 25871785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
    Sader HS; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren.
    Karlowsky JA; Jones ME; Draghi DC; Critchley IA; Thornsberry C; Sahm DF
    Diagn Microbiol Infect Dis; 2002 Jan; 42(1):59-64. PubMed ID: 11821173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
    Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
    Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper respiratory colonization by Streptococcus pneumoniae in healthy pre-school children in south-east Poland.
    Korona-Glowniak I; Niedzielski A; Malm A
    Int J Pediatr Otorhinolaryngol; 2011 Dec; 75(12):1529-34. PubMed ID: 21940056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006.
    Senok A; Al-Zarouni M; Al-Najjar J; Nublusi A; Panigrahi D
    J Infect Dev Ctries; 2007 Dec; 1(3):296-302. PubMed ID: 19734608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.